KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Other financing activities: 2018-2023

Historic Other financing activities for TherapeuticsMD (TXMD) over the last 6 years, with Dec 2023 value amounting to $1.3 million.

  • TherapeuticsMD's Other financing activities fell 79.28% to $23,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $298,000, marking a year-over-year increase of 7.97%. This contributed to the annual value of $1.3 million for FY2023, which is 61.74% down from last year.
  • Latest data reveals that TherapeuticsMD reported Other financing activities of $1.3 million as of FY2023, which was down 61.74% from $3.3 million recorded in FY2022.
  • Over the past 5 years, TherapeuticsMD's Other financing activities peaked at $6.7 million during FY2019, and registered a low of $1.2 million during FY2020.
  • In the last 3 years, TherapeuticsMD's Other financing activities had a median value of $3.3 million in 2022 and averaged $3.2 million.
  • In the last 5 years, TherapeuticsMD's Other financing activities slumped by 81.21% in 2020 and then surged by 309.44% in 2021.
  • TherapeuticsMD's Other financing activities (Yearly) stood at $6.7 million in 2019, then slumped by 81.21% to $1.2 million in 2020, then skyrocketed by 309.44% to $5.1 million in 2021, then slumped by 35.09% to $3.3 million in 2022, then slumped by 61.74% to $1.3 million in 2023.